Schedule 13G ownership disclosure
Juno Therapeutics, Inc.
Security class unavailable · CUSIP: 48205A109
Event date: 2017-12-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,680,487
- Percent of class
- 6.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001562230-18-000031
- Form type
- SC 13G
- Filer
- Capital International Investors
- CIK
- CIK 1562230
- Filed
- Feb 14, 2018
- Reporting period
- Dec 29, 2017
- Description
- Schedule 13G beneficial ownership